NCT05246072View on ClinicalTrials.gov

Effect of Combined Use of Ivermectin and Colchicine in COVID-19 Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

February 28, 2022

Study Completion Date

February 28, 2022

Conditions
COVID-19
Interventions
DRUG

Ivermectin + colchicine

In addition to the local standard of care for COVID 19 patients, the patient will receive Ivermectin + colchicine

DRUG

Colchicine

In addition to the local standard of care for COVID 19 patients, the patient will receive colchicine

Trial Locations (1)

11591

Ain Shams University hospitals, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT05246072 - Effect of Combined Use of Ivermectin and Colchicine in COVID-19 Patients | Biotech Hunter | Biotech Hunter